Sumitomo Pharma (DNPUF) Stock Chart & Stock Price History $6.53 0.00 (0.00%) As of 05/27/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Sumitomo Pharma Stock Price Performance The Sumitomo Pharma (DNPUF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 188.94%, with a year-to-date return of 58.11%. In the past month, the stock has increased 59.27%, reflecting recent market activity. As of the latest close, Sumitomo Pharma traded at $6.53 with a market cap of and volume of 0 shares. Five years ago, the stock traded at $14.25, representing a 54.18% decrease over that period. At the time, it had a market cap of and a volume of 70 shares. Receive DNPUF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sumitomo Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month PerformanceN/A3 Month Performance+30.60%Year-To-Date PerformanceN/A1 Year PerformanceN/A5 Year Performance-54.18% DNPUF Stock Chart for Friday, May, 30, 2025 DNPUF Chart by TradingView Sumitomo Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/05/2025$6.53$6.53$6.53$6.53250 shs$0.0005/02/2025$5.80$6.53+12.59%$6.53$6.53250 shs$0.0005/01/2025$4.10$5.80+41.46%$5.80$5.80100 shs$0.00 Related Companies 1933 Industries Stock Chart 4Cable TV International Stock Chart 4Front Ventures Stock Chart AB Science Stock Chart Abattis Bioceuticals Stock Chart Acreage Stock Chart Acreage Stock Chart Aleafia Health Stock Chart Almirall Stock Chart Alvotech Stock Chart Receive DNPUF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sumitomo Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:DNPUF) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sumitomo Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sumitomo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
